Cargando…
Outcomes of Surgical Excision and Brachytherapy in Intractable Keloids
BACKGROUND: Keloids as unusual scars are injury remnants characterized by bizarre cosmetics and painful itching. This study assessed outcomes of surgical excision and brachytherapy in intractable keloids. METHODS: Six patients with 10 keloid lesions were followed up. Surgical excision was done with...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Society for Plastic Surgeons
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714971/ https://www.ncbi.nlm.nih.gov/pubmed/29218275 |
_version_ | 1783283660609290240 |
---|---|
author | Taheri, Ahmadreza Molaei, Hojjat Aghili, Mehdi Rahmanpanah, Naser Mirmohseni, Atefeh |
author_facet | Taheri, Ahmadreza Molaei, Hojjat Aghili, Mehdi Rahmanpanah, Naser Mirmohseni, Atefeh |
author_sort | Taheri, Ahmadreza |
collection | PubMed |
description | BACKGROUND: Keloids as unusual scars are injury remnants characterized by bizarre cosmetics and painful itching. This study assessed outcomes of surgical excision and brachytherapy in intractable keloids. METHODS: Six patients with 10 keloid lesions were followed up. Surgical excision was done with 1-2 mm margin, and then radiotherapy was undertaken in 3 divided fractions on days 0, 1 and 2 after surgery. Scar improvement was evaluated by patients and observer with scar assessment scale (POSAS) RESULTS: Median age of patients was 38.3±6.4, while 40% were male and 60% were female. The mean primary size of the lesion before brachytherapy was 325.18±426.16 mm(2) and the median size was 153.48 mm(2). The mean primary size of the lesions with recurrence before brachytherapy was 150.50±124.78 mm(2). The clinical improvement of the scars with POSAS scoring by the observer was 17.1±3.2 and by the patients was 20.8±11.5. In 5 patients who were evaluated, two keloid lesions showed recurrence (20%), and 8 lesions had no recurrence (80%). No patients reported side effects, but only one patient, a 43 years old woman with 5 keloid lesions, suffered wound infection and local dehiscence of the wound, followed by the second session of brachytherapy. The average time of relapse was 26.3±0.9 months. CONCLUSION: The use of surgical resection in combination with brachytherapy was demonstrated as a modality for treatment of refractory keloid scars that can be recommended to surgeons who deal with these patients. |
format | Online Article Text |
id | pubmed-5714971 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Iranian Society for Plastic Surgeons |
record_format | MEDLINE/PubMed |
spelling | pubmed-57149712017-12-07 Outcomes of Surgical Excision and Brachytherapy in Intractable Keloids Taheri, Ahmadreza Molaei, Hojjat Aghili, Mehdi Rahmanpanah, Naser Mirmohseni, Atefeh World J Plast Surg Original Article BACKGROUND: Keloids as unusual scars are injury remnants characterized by bizarre cosmetics and painful itching. This study assessed outcomes of surgical excision and brachytherapy in intractable keloids. METHODS: Six patients with 10 keloid lesions were followed up. Surgical excision was done with 1-2 mm margin, and then radiotherapy was undertaken in 3 divided fractions on days 0, 1 and 2 after surgery. Scar improvement was evaluated by patients and observer with scar assessment scale (POSAS) RESULTS: Median age of patients was 38.3±6.4, while 40% were male and 60% were female. The mean primary size of the lesion before brachytherapy was 325.18±426.16 mm(2) and the median size was 153.48 mm(2). The mean primary size of the lesions with recurrence before brachytherapy was 150.50±124.78 mm(2). The clinical improvement of the scars with POSAS scoring by the observer was 17.1±3.2 and by the patients was 20.8±11.5. In 5 patients who were evaluated, two keloid lesions showed recurrence (20%), and 8 lesions had no recurrence (80%). No patients reported side effects, but only one patient, a 43 years old woman with 5 keloid lesions, suffered wound infection and local dehiscence of the wound, followed by the second session of brachytherapy. The average time of relapse was 26.3±0.9 months. CONCLUSION: The use of surgical resection in combination with brachytherapy was demonstrated as a modality for treatment of refractory keloid scars that can be recommended to surgeons who deal with these patients. Iranian Society for Plastic Surgeons 2017-09 /pmc/articles/PMC5714971/ /pubmed/29218275 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Taheri, Ahmadreza Molaei, Hojjat Aghili, Mehdi Rahmanpanah, Naser Mirmohseni, Atefeh Outcomes of Surgical Excision and Brachytherapy in Intractable Keloids |
title | Outcomes of Surgical Excision and Brachytherapy in Intractable Keloids |
title_full | Outcomes of Surgical Excision and Brachytherapy in Intractable Keloids |
title_fullStr | Outcomes of Surgical Excision and Brachytherapy in Intractable Keloids |
title_full_unstemmed | Outcomes of Surgical Excision and Brachytherapy in Intractable Keloids |
title_short | Outcomes of Surgical Excision and Brachytherapy in Intractable Keloids |
title_sort | outcomes of surgical excision and brachytherapy in intractable keloids |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714971/ https://www.ncbi.nlm.nih.gov/pubmed/29218275 |
work_keys_str_mv | AT taheriahmadreza outcomesofsurgicalexcisionandbrachytherapyinintractablekeloids AT molaeihojjat outcomesofsurgicalexcisionandbrachytherapyinintractablekeloids AT aghilimehdi outcomesofsurgicalexcisionandbrachytherapyinintractablekeloids AT rahmanpanahnaser outcomesofsurgicalexcisionandbrachytherapyinintractablekeloids AT mirmohseniatefeh outcomesofsurgicalexcisionandbrachytherapyinintractablekeloids |